Topics

Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 06/02/2009, Revision: 16, Status: Authorised

07:36 EDT 9 Jul 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 06/02/2009, Revision: 16, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 06/02/2009, Revision: 16, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 06/02/2009, Revision: 16, Status: Authorised"

Quick Search

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...